MSCI reviews FM Index

Published
0

KARACHI: Global investment index provider MSCI has removed MCB Bank from its main Frontier Market Index and added it to the MSCI Frontier Market Small-Cap Index.

According to a report by Topline Securities on Monday, the semi-annual review announcement on Nov 10 showed Pakistan has now only two constituents left in the MSCI Frontier Market Index, namely Lucky Cement Ltd and Oil and Gas Development Company Ltd.

MSCI did not notify Pakistan’s weight in the index, but the brokerage estimated it to be 0.7 per cent. The changes to the MSCI Frontier Market Index will be effective from Nov 30.

As per the benchmark provider’s market classification framework, size and liquidity requirements for the constituents of the Frontier Market Index include full-cap market size of $1 billion, free-float market capitalisation of $91 million, and 2.5pc of annualised traded value ratio.

Pakistan was reclassified into the MSCI Frontier Market from the Emerging Market in November 2021.

Published in Dawn, November 15th, 2022

Opinion

Editorial

Nuclear uncertainty
Updated 23 Oct, 2026

Nuclear uncertainty

With matters frozen in the political and diplomatic spheres, it will take military-to-military engagement to prevent miscalculation in the strategic sphere.
Auto illusion
Updated 23 Oct, 2026

Auto illusion

PAKISTAN’S draft auto policy 2026-31 is ambitious in its targets and directionless in its strategy. It promises...
Two crimes
23 Oct, 2026

Two crimes

THE senseless killing of a teenager by his employers in Multan is a crime that deserves unqualified condemnation. It...
Makkah pact clarity
Updated 22 Oct, 2026

Makkah pact clarity

Fresh aggression can kick off a firestorm that will be in no one’s control, hence it is best to abandon such reckless plans.
Common ground
Updated 22 Oct, 2026

Common ground

Regrettably, the two sides still fail to see the country’s economic, security, and governance crises as challenges that must be solved politically.
The treatment gap
22 Oct, 2026

The treatment gap

A BREAST cancer diagnosis no longer carries the bleak outlook it did a generation ago. Targeted medicines,...